Basil Fathalla

Dr. Basil Fathalla

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2016 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
TMTaha Moussa
Taha Moussa
VBVenkatraman Bhat
Venkatraman Bhat
VKVishwanatha Kini
Vishwanatha Kini
BFBasil Fathalla
Basil Fathalla

1 October 2008 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
BFBasil Fathalla
Basil Fathalla
DGDonald P. Goldsmith
Donald P. Goldsmith
JPJudy Mae C. Pascasio
Judy Mae C. Pascasio
ABAlan Baldridge
Alan Baldridge

15 November 2013 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
SCShanmuganathan Chandrakasan
Shanmuganathan Chandrakasan
SCSaurabh Chiwane
Saurabh Chiwane
MAMatthew Adams
Matthew Adams
BFBasil Fathalla
Basil Fathalla

18 November 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
F(for Pediatric Arab Rheumatology Group (PRAG)
for Pediatric Arab Rheumatology Group (PRAG)
SASulaiman M. Al-Mayouf
Sulaiman M. Al-Mayouf
AAAbdulaziz Almutairi
Abdulaziz Almutairi
SASafiya Albrawi
Safiya Albrawi
BFBasil Fathalla
Basil Fathalla
NANora Almuatiri
Nora Almuatiri

1 June 2013 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
TBTuan Bui
Tuan Bui
SCShanmuganathan Chandrakasan
Shanmuganathan Chandrakasan
JPJanet Poulik
Janet Poulik
BFBasil Fathalla
Basil Fathalla
Granulomatosis with polyangiitis (GPA), formerly known as Wegener granulomatosis, in children is an uncommon chronic organ- and life-threatening systemic vasculitis that may share at time of initial presentation a number of clinical features in common with Henoch-Schönlein purpura (HSP), a very common and comparatively benign form of childhood vasculitis. Diagnosis of GPA requires a high index of suspicion, and antineutrophil cytoplasmic antibody tests along with tissue biopsy are helpful tools for diagnosis. We report 2 patients with GPA masqueraded as HSP at time of initial presentation. Both patients presented with nonthrombocytopenic purpura on lower extremities, in addition to abdominal pain, and/or microscopic hematuria and fulfilled both the American College of Rheumatology and the Pediatric Rheumatology European Society classification criteria for HSP. Both patients eventually developed significant renal and pulmonary disease and were diagnosed with GPA. We aim to raise awareness of such atypical presentations of GPA to avoid delayed management.

3 December 2024 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
BFBasil Fathalla
Basil Fathalla
RTRonald Thomas
Ronald Thomas
Objectives: The aim of this study was to report the spectrum of Familial Mediterranean Fever (FMF) in children living in Southeast Michigan. Methods: We reviewed prerecorded data in medical records of FMF patients. Statistical analysis of the data included Fisher exact test, Pearson χ2 procedure, parametric independent samples t test, and parametric analysis of variance using SPSS Version 29.0, IBM Inc. Results: The study included 29 males and 21 females. The mean age at presentation was 4.63 ± 3.66 years, and the mean time to diagnosis was 2.1 ± 2.18 years. A slight majority presented in the first 3 years of age (54%). Family history of FMF was reported in only 58% of patients. Clinical manifestations included fever (84%), gastrointestinal (84%), musculoskeletal (64%; including chronic arthritis, sacroiliitis, and nonbacterial osteomyelitis), chest (28%), cutaneous (14%), and other manifestations (16%). Fever without other manifestations was reported only in patients presenting at ≤3 years of age (p = 0.016), whereas older patients reported more gastrointestinal manifestations (p = 0.04). Reported MEFV variants included p.M694V (n = 26), p.V726A (n = 23), p.M694I (n = 13), and others (n = 10). Homozygote and compound heterozygote patients had more gastrointestinal manifestations (p < 0.001), whereas fever was more common in the heterozygote patients (p = 0.04). The mean follow-up period was 5.34 ± 4.13 years with no renal disease. Conclusions: We report the largest childhood FMF cohort in the United States. A negative family history should not preclude consideration of FMF as a cause of periodic fever. Recurrent fever can be the only manifestation, particularly in young patients with FMF. The absence of fever and chronic progressive musculoskeletal manifestations can uncommonly occur.